Tedizolid (formerly torezolid, trade name Sivextro) is an oxazolidinone-class antibiotic for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)). Tedizolid has been approved by the U.S Food and Drug Administration on June 20, 2014.
Product Name: Tedizolid
Synonyms: Torezolid; TR-700
CAS Number: 856866-72-3
Molecular Weight:  370.3423
Molecular Formula:  C17H15FN6O3
Purity (HPLC): ≥99%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.